Enliven Therapeutics, Inc. ELVN

44.75 (0.42) (0.93%) as of 25 Sep
Market cap
$3.3B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

477.57 462.62 452.40 895.16
Total current assets
482.68 474.88 463.14 907.34
Property, Plant, Equpment (Net)
0.40 0.03 0.02 0.14
Long-term assets (Other)
7.10 0.66 1.19 1.24
Total non-current assets
8.19 1.29 1.72 2.88
Total Assets
490.88 476.17 464.85 910.22
Accounts Payable
1.43 2.16 1.64 0.37
Accrued Expenses
13.22 14.41 9.85 13.79
Total current liabilities
14.65 16.57 11.49 14.16
Non-current Liabilities (Other)
0.10 — — 0.91
Total non-current liabilities
0.10 — — 0.91
Total liabilities
14.75 16.57 11.49 15.07
Additional Paid In Capital
793.34 806.37 824.48 1,300.26
Common Stock (Net)
0.06 0.06 0.06 0.07
Retained Earnings
(317.50) (347.17) (370.79) (403.28)
Common Equity (Total)
476.12 459.60 453.37 895.15
Shareholders Equity (Total)
476.12 459.60 453.37 895.15
Shareholders Equity and Liabilities (Total)
490.88 476.17 464.85 910.22
Shares (Common)
59.26 59.44 60.89 73.25
Shareholders Equity (Tangible)
476.12 459.60 453.37 895.15
Net Debt
(477.56) (462.62) (452.40) (895.15)

Fold the line items

In millions of $ except per-share values · columns are period end dates